W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.
W. L. Gore & Associates' medical business (Gore) has announced the FDA approval of the GORE® VIABAHN® FORTEGRA Venous Stent — ...
THE rationale for venous ligation in pulmonary embolic disease is based on its assumed ability to prevent subsequent emboli from reaching the lungs. The level of the inferior vena cava is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback